サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1683389

音声認識技術を搭載したスマート補聴器の世界市場：2025年～2033年

Global Smart Hearing Aids with Speech Recognition Technology Market - 2025-2033

出版日
ページ情報
英文 215 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
音声認識技術を搭載したスマート補聴器の世界市場：2025年～2033年
出版日: 2025年03月20日
発行: DataM Intelligence
ページ情報: 英文 215 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の音声認識技術を搭載したスマート補聴器の市場規模は、2024年に78億7,000万米ドルに達し、2033年には308億3,000万米ドルに達すると予測され、予測期間の2025年～2033年のCAGRは14.6%となる見込みです。

スマート補聴器は、難聴者の生活の質を向上させる先進的な機器です。スマート補聴器は、ワイヤレス接続と人工知能を利用して、さまざまな聞き取り環境に適応し、周囲の雑音を低減し、音声の明瞭度を高める。複数のデジタル補聴器をスマートフォンに接続することで、設定を調整したり、音声をストリーミングしたり、リアルタイムの言語翻訳を受けたりすることができます。また、事故の検知や脈拍数のモニタリングなど、健康管理機能を備えたモデルもあります。スマート補聴器は、個別化された音響体験を提供することで、コミュニケーション、社会参加、自立性を高めます。

AIと音声認識技術のスマート補聴器への統合が市場の成長を促進しています。これらのAIを搭載した補聴器は、さまざまなリスニング環境に適応し、バックグラウンドノイズをフィルタリングし、リアルタイムで音声の明瞭度を高めることができます。音声コマンド、自動音量調整、機械学習に基づく音のパーソナライズなどの機能は、特に軽度から重度の難聴のユーザーを魅了しています。

AIアルゴリズムやディープラーニングモデルの継続的な開発により、その機能はさらに強化されると予想されます。例えば、2025年2月、補聴器イノベーションの世界的リーダーであるGNは、世界最小のAI搭載補聴器であるReSound Viviaと、Bluetooth LE Audioとオーラキャスト放送音声を搭載したエッセンシャルシリーズであるReSound Saviを発売しました。これらの補聴器は、サイズと電池寿命を維持しながら、優れた音質と騒音下での快適性を提供します。GNのAIモデルは、自然な音声処理機能に重点を置いています。

世界のスマート補聴器市場は、高度な補聴器、特に音声認識技術を搭載したAI内蔵補聴器に関連する高コストのために課題に直面しています。このため、特に高齢者や、保険や保険適用が限られている発展途上地域の人々にとっては、これらの補聴器は利用しにくいものとなっています。例えば、補聴器1台にかかる費用は1,000ドルから3,500ドルで、1組の補聴器にかかる費用は4年間で1日あたり約5.57ドルとなり、ラテ代に相当します。

さらに、メンテナンス費用、電池交換、限られた払い戻し政策が、こうした高度な補聴器の普及をさらに妨げています。

当レポートでは、世界の音声認識技術を搭載したスマート補聴器市場について調査し、市場の概要とともに、製品タイプ別、難聴タイプ別、技術別、患者タイプ別、流通チャネル別、地域別動向、競合情勢、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 調査手法と範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
    • 抑制要因
    • 機会
    • 影響分析

第5章 戦略的洞察と業界の展望

  • 市場のリーダーと先駆者
  • CXOの視点
  • 最新の開発とブレークスルー
  • ケーススタディ/進行中の調査
  • 規制と償還の情勢
  • ポーターのファイブフォース分析
  • パイプライン分析
  • サプライチェーン分析
  • 特許分析
  • SWOT分析
  • アンメットニーズとギャップ
  • 市場参入と拡大のための推奨戦略
  • シナリオ分析ベストケース、ベースケース、ワーストケースの予測
  • 価格分析と価格動向
  • キーオピニオンリーダー

第6章 製品タイプ別

  • BTE
  • RITE
  • ITE
  • ITC
  • その他

第7章 難聴タイプ別

  • 感音難聴
  • 伝音性難聴
  • 混合性難聴

第8章 技術別

  • デジタル
  • アナログ

第9章 患者グループ別

  • 成人
  • 小児

第10章 流通チャネル別

  • 病院
  • 外来手術センター（ASC）
  • 在宅ケア

第11章 地域別

  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他
  • ラテンアメリカ
    • メキシコ
    • ブラジル
    • アルゼンチン
    • その他
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他
  • 中東・アフリカ

第12章 競合情勢

第13章 企業プロファイル

  • Sonova
  • Starkey Hearing Technologies
  • GN Hearing A/S
  • Demant
  • Eargo
  • Ambiq
  • WS Audiology A/S
  • Eargo
  • Olive Union
  • Lyric Hearing

第14章 付録

目次
Product Code: MD9337

The global smart hearing aids with speech recognition technology market reached US$ 7.87 billion in 2024 and is expected to reach US$ 30.83 billion by 2033, growing at a CAGR of 14.6% during the forecast period 2025-2033.

Smart hearing aids are advanced devices that improve the quality of life for individuals with hearing loss. They use wireless connectivity and artificial intelligence to adapt to different listening environments, reduce background noise, and enhance speech clarity. Users can adjust settings, stream audio, and receive real-time language translation by connecting multiple digital hearing aids to smartphones. Some models also have health-tracking capabilities, detecting accidents and monitoring pulse rate. Smart hearing aids enhance communication, social engagement, and independence by providing personalized sound experiences.

Market Dynamics: Drivers & Restraints

Advancements in Artificial Intelligence and Speech Recognition

The integration of AI and speech recognition technology in smart hearing aids is driving market growth. These AI-powered aids can adapt to different listening environments, filter background noise, and enhance speech clarity in real-time. Features like voice commands, automatic volume adjustments, and machine learning-based sound personalization attract users, particularly those with mild to severe hearing loss.

The continuous development of AI algorithms and deep learning models is expected to further enhance their capabilities. For instance, in February 2025, GN, the global leader in hearing aid innovation, launched the ReSound Vivia, the world's smallest AI-powered hearing aid, and the ReSound Savi, an essentials range featuring Bluetooth LE Audio and Auracast broadcast audio. These hearing aids offer superior sound quality and comfort in noisy environments while maintaining size and battery life. GN's AI model focuses on natural sound processing capabilities.

High Cost of Advanced Hearing Aids

The global smart hearing aids market faces challenges due to the high costs associated with advanced devices, particularly AI-integrated ones with speech recognition technology. This makes these devices less accessible, especially for elderly individuals and those in developing regions with limited insurance coverage and insurance coverage. For instance, The cost of one hearing aid can range from $1,000 to $3,500, with a pair of hearing aids costing about $5.57 per day over four years, equivalent to the cost of a latte.

Additionally, maintenance costs, battery replacements, and limited reimbursement policies further hinder the widespread adoption of these advanced hearing aids.

Segment Analysis

The global smart hearing aids with speech recognition technology market is segmented based on product type, hearing loss type, technology, patient group, distribution channel, and region.

Product Type:

Behind-the-Ear (BTE) segment in the product type is expected to dominate the smart hearing aids with speech recognition technology market

Behind-the-ear (BTE) hearing aids are a key segment in the global smart hearing aids with speech recognition technology market due to their advanced features, comfort, and adaptability. They use advanced speech recognition technology to enhance speech clarity, filter background noise, and improve voice detection in noisy environments. Their wireless connectivity allows seamless integration with smartphones and other smart devices, making them popular among tech-savvy users. The growing prevalence of age-related hearing loss and demand for AI-powered hearing solutions further fuel the market expansion of BTE smart hearing aids.

Additionally, market players are introducing advanced hearing aids. For instance, in October 2024, ELEHEAR launched its latest innovation, ELEHEAR Beyond Hearing Aids, which uses advanced AI technology to enhance sound clarity, provide customizable tinnitus relief, and offer seamless Bluetooth streaming. These hearing aids are priced at an affordable price, making premium hearing aid technology accessible to the masses without compromising quality.

Geographical Analysis

North America is expected to hold a significant position in the smart hearing aids with speech recognition technology market

North America is a significant contributor to the global smart hearing aids with speech recognition technology market, as evidenced by the rapid adoption of advanced healthcare technologies, the increase in the prevalence of hearing impairment, and the geriatric population. For instance, according to WHO, moreover, 5% of the world's population, or 430 million individuals, need rehabilitation for their debilitating hearing loss. It is anticipated that by 2050, approximately 700 million individuals, or one out of every ten, will have debilitating hearing loss. Disabling hearing loss is defined as hearing loss of more than 35 decibels (dB) in the better-hearing ear.

Moreover, strong R&D investments in the region have resulted in ongoing advancements in AI-powered speech recognition and wireless connectivity in hearing aids also significant factors that help the region to grow during the forecast period.

Competitive Landscape

The major global players in the smart hearing aids with speech recognition technology market include Sonova, Starkey Hearing Technologies, GN Hearing A/S, Demant, Eargo, Ambiq, and WS Audiology A/S among others.

Key Developments

  • In February 2025, Beltone introduced its latest innovation, Beltone Envision hearing aids, which offer the world's best technology for noise management and voice clarity. These aids keep users connected to their surroundings and bring important sounds into clear focus, enhancing their listening experience.

Why Purchase the Report?

  • Technological Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Product Type & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

The global smart hearing aids with speech recognition technology market report delivers a detailed analysis with 69 key tables, more than 70 visually impactful figures, and 215 pages of expert insights, providing a complete view of the market landscape.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Hearing Loss Type
  • 3.3. Snippet by Technology
  • 3.4. Snippet by Patient Group
  • 3.5. Snippet by Distribution Channel
  • 3.6. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Advancements in Artificial Intelligence and Speech Recognition
      • 4.1.1.2. Rise in the Prevalence of Hearing Disorders
    • 4.1.2. Restraints
      • 4.1.2.1. High Cost of Advanced Hearing Aids
      • 4.1.2.2. Stringent Regulatory Requirements
    • 4.1.3. Opportunity
      • 4.1.3.1. Expansion into Emerging Markets
    • 4.1.4. Impact Analysis

5. Strategic Insights and Industry Outlook

  • 5.1. Market Leaders and Pioneers
    • 5.1.1. Emerging Pioneers and Prominent Players
    • 5.1.2. Established leaders with largest selling Brand
    • 5.1.3. Market leaders with established Product
  • 5.2. CXO Perspectives
  • 5.3. Latest Developments and Breakthroughs
  • 5.4. Case Studies/Ongoing Research
  • 5.5. Regulatory and Reimbursement Landscape
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East & Africa
  • 5.6. Porter's Five Force Analysis
  • 5.7. Pipeline Analysis
  • 5.8. Supply Chain Analysis
  • 5.9. Patent Analysis
  • 5.10. SWOT Analysis
  • 5.11. Unmet Needs and Gaps
  • 5.12. Recommended Strategies for Market Entry and Expansion
  • 5.13. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 5.14. Pricing Analysis and Price Dynamics
  • 5.15. Key Opinion Leaders

6. By Product Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 6.1.2. Market Attractiveness Index, By Product Type
  • 6.2. Behind-the-Ear (BTE)*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Receiver-in-the-Ear (RITE)
  • 6.4. In-the-Ear (ITE)
  • 6.5. In-the-Canal (ITC)
  • 6.6. Others

7. By Hearing Loss Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Hearing Loss Type
    • 7.1.2. Market Attractiveness Index, By Hearing Loss Type
  • 7.2. Sensorineural Hearing Loss*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Conductive Hearing Loss
  • 7.4. Mixed Hearing Loss

8. By Technology

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 8.1.2. Market Attractiveness Index, By Technology
  • 8.2. Digital*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Analog

9. By Patient Group

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Patient Group
    • 9.1.2. Market Attractiveness Index, By Patient Group
  • 9.2. Adult*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Pediatric

10. By Distribution Channel

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 10.1.2. Market Attractiveness Index, By Distribution Channel
  • 10.2. Hospitals*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Ambulatory Surgical Centers (ASCs)
  • 10.4. Home Care Settings

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Hearing Loss Type
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Patient Group
    • 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.8.1. U.S.
      • 11.2.8.2. Canada
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Hearing Loss Type
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Patient Group
    • 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.8.1. Germany
      • 11.3.8.2. U.K.
      • 11.3.8.3. France
      • 11.3.8.4. Spain
      • 11.3.8.5. Italy
      • 11.3.8.6. Rest of Europe
  • 11.4. Latin America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Hearing Loss Type
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Patient Group
    • 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.8.1. Mexico
      • 11.4.8.2. Brazil
      • 11.4.8.3. Argentina
      • 11.4.8.4. Rest of South America
  • 11.5. Asia-Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Hearing Loss Type
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Patient Group
    • 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.8.1. China
      • 11.5.8.2. India
      • 11.5.8.3. Japan
      • 11.5.8.4. South Korea
      • 11.5.8.5. Rest of Asia-Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Hearing Loss Type
    • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Patient Group
    • 11.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel

12. Competitive Landscape

  • 12.1. Competitive Scenario
  • 12.2. Market Positioning/Share Analysis
  • 12.3. Mergers and Acquisitions Analysis

13. Company Profiles

Key Market Players

  • 13.1. Sonova*
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio
      • 13.1.2.1. Product Description
      • 13.1.2.2. Product Key Performance Indicators (KPIs)
      • 13.1.2.3. Historic and Forecasted Product Sales
      • 13.1.2.4. Product Sales Volume
    • 13.1.3. Financial Overview
      • 13.1.3.1. Company Revenue's
      • 13.1.3.2. Geographical Revenue Shares
      • 13.1.3.3. Revenue Forecasts
    • 13.1.4. Key Developments
      • 13.1.4.1. Mergers & Acquisitions
      • 13.1.4.2. Key Product Development Activities
      • 13.1.4.3. Regulatory Approvals etc.
    • 13.1.5. SWOT Analysis
  • 13.2. Starkey Hearing Technologies
  • 13.3. GN Hearing A/S
  • 13.4. Demant
  • 13.5. Eargo
  • 13.6. Ambiq
  • 13.7. WS Audiology A/S
  • Similar data will be provided for each market player.

Emerging Market Players

  • 13.8. Eargo*
    • 13.8.1. Pipeline Products Description
    • 13.8.2. Product Key Performance Indicators (KPIs)
    • 13.8.3. Key Activities
    • 13.8.4. Market Entry Timelines
    • 13.8.5. Product Penetration Rate
    • 13.8.6. Sales Estimation and Projections
  • 13.9. Olive Union
  • 13.10. Lyric Hearing
  • Similar data will be provided for each market player.

LIST NOT EXHAUSTIVE

14. Appendix

  • 14.1. About Us and Services
  • 14.2. Contact Us